{"id":"NCT04847557","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-04-20","primaryCompletion":"2024-07-02","completion":"2024-07-02","firstPosted":"2021-04-19","resultsPosted":"2025-08-20","lastUpdate":"2025-08-20"},"enrollment":731,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Obesity","Heart Failure With Preserved Ejection Fraction (HFpEF)"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Tirzepatide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejection fraction and obesity.","primaryOutcome":{"measure":"Change From Baseline in the Kansas City Cardiomyopathy Questionnaire (KCCQ) Clinical Summary Score (CSS)","timeFrame":"Baseline, Week 52","effectByArm":[{"arm":"Tirzepatide - MTD","deltaMin":19.51,"sd":1.24},{"arm":"Placebo","deltaMin":12.68,"sd":1.25}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":8},"locations":{"siteCount":146,"countries":["United States","Argentina","Brazil","China","India","Israel","Mexico","Puerto Rico","Russia","Taiwan"]},"refs":{"pmids":["40903131","40701669","40162940","39566869","39556714","39555826","39551891"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/4deAJHqkMfFYm9JjtgeqTl"]},"adverseEventsSummary":{"seriousAny":{"events":96,"n":364},"commonTop":["Diarrhoea","Nausea","Constipation","Covid-19","Urinary tract infection"]}}